Article 100. Principles of approval of a bioequivalence trial of a drug
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
Bioequivalence trial of drugs
1. A bioequivalence trial of a drug shall be conducted only after the dossier of the bioequivalence trial has been scientifically and ethically assessed by the establishment’s council of ethics in biomedical research and the trial is approved in writing by the person responsible for professional activities of the establishment conducting the bioequivalence trial.
2. The approval of a bioequivalence trial of a drug must comply with the following principles:
a/ The principles specified at Points a, b and c, Clause 2, Article 94 of this Law;
b/ Strict observance of the good clinical trial practices, good laboratory practices in biofluid analysis, and of the bioequivalence trial guidelines issued by the Minister of Health.
3. The establishment’s council of ethics in biomedical research shall assess scientific and ethical matters in the dossier for bioequivalence trial of a drug and approve the research outline.
Article 100, Law 105/2016/QH13